SaveHealth reports on cholesterol medications, detailing common types like statins, their effects, and safety considerations ...
A new discovery may explain why so many people abandon cholesterol-lowering statins because of muscle pain and weakness.
Statins are the go-to medications for lowering “bad” LDL cholesterol, reducing the risk of cardiovascular disease and ...
Oprah Winfrey discusses GLP-1 weight-loss medications and obesity as a disease, challenging long-held misconceptions about ...
The reason statins are so widely prescribed is because they work. They’re often prescribed as the first level of defense.
A study published this week in The BMJ suggests that the blockbuster GLP-1 weight-loss drugs, better known by their brand names Ozempic, Wegovy, and Mounjaro, work the same way. If you stop taking ...
By Athena Vlachou Drugs used to treat metabolic disorders, such as Type 2 diabetes, alleviate symptoms of Alzheimer's disease ...
Biologically, how the GLP-1 is delivered into the body should make little difference: It’s the same peptide, just in a ...
Friendly” labels on the packaging are becoming more common in U.S. supermarkets as a growing number of Americans try obesity ...
Health Canada approved last month two  brand names for generic semaglutide products, Plosbrio  and  Poviztra, which contain ...
Dan Bessesen, MD, a health and wellness leader at CU Anschutz, offers key insights on weight loss drugs, particularly compounded GLP-1s that are banned by the FDA but continue to be available.
There are two drugs on the market - semaglutide, marketed under the brand name Wegovy, and tirzepatide, sold as Mounjaro.